|
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants |
147.9 |
|
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome |
120.59 |
|
Control of prostate tumour growth by the long non-coding RNA GHSROS |
88.72 |
|
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. |
87.78 |
|
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis |
75.81 |
|
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] |
57.47 |
|
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) |
55.9 |
|
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells |
54.01 |
|
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] |
53.73 |
|
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies |
53.73 |
|
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID |
53.48 |
|
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state |
50.42 |
|
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs |
48.62 |
|
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells |
46.83 |
|
Inhibition of TNBC metastasis by Gpx1 |
45.02 |
|
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 |
41.19 |
|
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization |
40.94 |
|
naive T cell heterogeneity after neonatal thymectomy |
37.44 |
|
RNA-seq of stable and unstable section of human atherosclerotic plaques |
36.51 |
|
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] |
36.32 |
|
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes |
36.26 |
|
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] |
36.22 |
|
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations |
36.22 |
|
RNA-seq in SUNE-1 cells after downregulation of DANCR expression |
35.81 |
|
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor |
35.65 |
|
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome |
34.82 |
|
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis |
34.74 |
|
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq |
34.49 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] |
33.11 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia |
33.11 |
|
Fbxo32 mediated gene expression program underlies EMT and metastasis |
32.52 |
|
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics |
32.09 |
|
Mutational landscape of splicing genes and functional consequences across 33 cancer types |
32.05 |
|
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms |
31.24 |
|
Transcriptional profiles of normal human mature B cells |
28.78 |
|
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] |
28.31 |
|
Transcriptome profiling of Normal and Cancerous Prostate Cells |
26.74 |
|
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma |
26.71 |
|
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity |
26.24 |
|
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells |
25.95 |
|
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 |
25.69 |
|
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation |
25.48 |
|
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation |
25.17 |
|
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] |
25.17 |
|
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption |
24.87 |
|
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance |
24.83 |
|
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 |
24.8 |
|
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis |
24.55 |
|
Transcriptome of human keratinocytes with or without HPV16 oncogene expression |
24.44 |
|
MEIS1 regulates hematopoiesis in hPSCs |
23.85 |
|
FOXD3 is a novel tumor suppressor in lung cancer |
23.68 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] |
23.67 |
|
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma |
23.4 |
|
RNAseq of IL-36 stimulated primary human keratinocytes |
23.21 |
|
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells |
23.17 |
|
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells |
23.17 |
|
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing |
22.81 |
|
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] |
22.81 |
|
Regulating Interleukin-2 activity with engineered receptor signaling clamps |
22.56 |
|
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma |
22.3 |
|
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors |
21.98 |
|
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation |
21.98 |
|
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates |
21.94 |
|
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms |
21.43 |
|
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer |
21.36 |
|
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES |
21.28 |
|
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] |
21.28 |
|
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection |
21.23 |
|
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] |
21.03 |
|
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) |
21.03 |
|
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . |
20.96 |
|
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer |
20.95 |
|
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
20.89 |
|
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines |
20.63 |
|
Highly-motile versus unsorted MDA-MB-231 breast cancer cells |
20.23 |
|
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. |
19.97 |
|
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation |
19.64 |
|
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] |
19.34 |
|
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells |
19.34 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] |
18.96 |
|
Gene Expression Profiling of SPOP Knocked Down Cell |
18.89 |
|
Investigate A2M treatment on human prostate cancer and mouse liver |
18.29 |
|
Investigate A2M treatment on human prostate cancer xenograft in mice |
18.29 |
|
Rorc disruption in human FG pancreatic cancer cells |
17.68 |
|
Gene expression profile of multiple myeloma cell lines treated with CB-5083 |
17.57 |
|
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation |
17.45 |
|
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] |
17.43 |
|
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis |
17.43 |
|
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] |
17.36 |
|
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors |
17.36 |
|
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. |
17.36 |
|
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells |
17.25 |
|
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division |
17.25 |
|
Global analysis of alternative splicing regulated by RBM10 |
17.22 |
|
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML |
16.95 |
|
Knockdown of FOXP1 promotes the development of lung adenocarcinoma |
16.78 |
|
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells |
16.64 |
|
Generation and functional characterization of MDSC-like cells |
16.64 |
|
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes |
16.61 |
|
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol |
16.42 |
|
Stem and effector CD8 T-cells from human cancers |
16.28 |
|
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 |
16.27 |
|
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines |
16.17 |
|
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] |
16.13 |
|
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium |
16.13 |
|
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression |
15.99 |
|
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I |
15.95 |
|
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis |
15.56 |
|
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients |
15.52 |
|
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA |
15.47 |
|
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells |
15.37 |
|
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression |
15.02 |
|
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors |
14.9 |
|
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression |
14.85 |
|
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells |
14.69 |
|
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment |
14.63 |
|
Paxillin regulates genomic networks in prostate cancer [PC3] |
14.6 |
|
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks |
14.43 |
|
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production |
14.2 |
|
Effects of rFVIIIFc on human macrophages |
14.19 |
|
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
14.07 |
|
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets |
13.87 |
|
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells |
13.85 |
|
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines |
13.83 |
|
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site |
13.81 |
|
CD86 regulates a pro-survival signal in myeloma cells |
13.79 |
|
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells |
13.78 |
|
Intrahepatic MAIT cell gene expression revealed by RNA-seq |
13.76 |
|
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer |
13.57 |
|
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment |
13.49 |
|
Primary Human B-cell Temporal Response to CD40L Stimulation |
13.41 |
|
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells |
13.36 |
|
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells |
13.34 |
|
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib |
13.3 |
|
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing |
13.17 |
|
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] |
12.98 |
|
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells |
12.98 |
|
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition |
12.92 |
|
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] |
12.92 |
|
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 |
12.88 |
|
Splicing and epigenetic factors jointly regulate epidermal differentiation |
12.85 |
|
RNA-seq of MDA-MB-231 cells with TET1 knockout |
12.43 |
|
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing |
12.41 |
|
JAK dependent survival of ALK- ALCL |
12.28 |
|
Lipid degradation promotes prostate cancer cell survival |
12.22 |
|
A novel target of EZH1/2 for treatment of mantle cell lymphoma |
12.17 |
|
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis |
12.13 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] |
11.81 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis |
11.81 |
|
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) |
11.71 |
|
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). |
11.67 |
|
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L |
11.6 |
|
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells |
11.55 |
|
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT |
11.47 |
|
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation |
11.32 |
|
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] |
11.32 |
|
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] |
11.3 |
|
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors |
11.25 |
|
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) |
10.92 |
|
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia |
10.71 |
|
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq |
10.66 |
|
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray |
10.66 |
|
Generation of KRAS signatures using immortalized isogenic lung cells. |
10.63 |
|
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies |
10.41 |
|
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation |
10.35 |
|
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq |
10.33 |
|
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq |
10.31 |
|
Transcriptome analysis of U87 cells upon LINC00152 knockdown |
10.19 |
|
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 |
10.14 |
|
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) |
10.1 |
|
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics |
10.1 |
|
Ro60-knockout cells |
10.01 |
|
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG |
9.96 |
|
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity |
9.92 |
|
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer |
9.87 |
|
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses |
9.87 |
|
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction |
9.86 |
|
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] |
9.84 |
|
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells |
9.84 |
|
GATA3-mediated chromatin reprogramming in breast cancer cells |
9.79 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) |
9.78 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes |
9.78 |
|
CSL RNA-Seq on HKC and SCC cell lines |
9.76 |
|
CSL |
9.76 |
|
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment |
9.76 |
|
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model |
9.57 |
|
Characterisation of the myeloid differentiation process of human hematopoietic stem cells |
9.53 |
|
The role of the Calcium-Sensing receptor in colorectal cancer |
9.52 |
|
Transcriptome of activated human and mouse MAIT cells |
9.47 |
|
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells |
9.38 |
|
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation |
9.36 |
|
Human neutrophil genome during PMA- and E. coli encounter-induced activation |
9.36 |
|
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells |
9.36 |
|
Transcriptomes of oxLDL exposed trained monocytes |
9.27 |
|
oxLDL exposed trained monocytes |
9.27 |
|
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth |
9.18 |
|
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells |
9.18 |
|
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing |
9.14 |
|
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions |
9.12 |
|
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] |
9.09 |
|
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches |
9.03 |
|
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer |
9.02 |
|
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium |
9.02 |
|
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination |
8.95 |
|
circNFIB suppresses lymphatic metastasis of pancreatic cancer |
8.89 |
|
RNA seq_PDX2_SHP099 |
8.85 |
|
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling |
8.74 |
|
Proliferation-correlated expression |
8.7 |
|
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis |
8.66 |
|
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. |
8.65 |
|
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] |
8.58 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
8.55 |
|
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor |
8.52 |
|
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression |
8.45 |
|
circRNA profile in hypopharyngeal cancer |
8.2 |
|
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype |
8.18 |
|
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] |
8.14 |
|
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer |
8.11 |
|
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation |
8.08 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) |
8.07 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis |
8.07 |
|
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection |
8.0 |
|
FOXO1 is an oncogenic mediator in AML1-ETO leukemia |
7.97 |
|
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome |
7.93 |
|
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells |
7.91 |
|
Gene expression activation in CLL mediated by MSCs contact |
7.78 |
|
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution |
7.77 |
|
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] |
7.72 |
|
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq |
7.69 |
|
Differential gene expression profiles in imatinib-resistant cell lines |
7.69 |
|
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing |
7.67 |
|
Short and Long RNA sequencing of human mature erythrocytes |
7.67 |
|
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) |
7.64 |
|
BACH2 in human plasma cell fate decision |
7.59 |
|
The role of FAM46C in myeloma cells |
7.58 |
|
The role of FAM46C in myeloma cells [sequencing] |
7.58 |
|
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia |
7.51 |
|
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] |
7.49 |
|
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells |
7.47 |
|
Functional studies of missense TREM2 mutations in human stem cell-derived microglia |
7.42 |
|
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway |
7.41 |
|
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells |
7.39 |
|
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients |
7.25 |
|
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis |
7.23 |
|
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells |
7.2 |
|
Downregulation of LATS kinases alters p53 to promote cell migration |
7.16 |
|
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors |
7.11 |
|
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] |
7.11 |
|
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures |
7.11 |
|
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer |
6.99 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes |
6.97 |
|
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells |
6.97 |
|
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) |
6.97 |
|
Landscape and variation of RNA secondary structure across the human transcriptome |
6.93 |
|
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition |
6.88 |
|
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. |
6.88 |
|
Bone marrow derived human B cells [normal proB] |
6.81 |
|
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis |
6.74 |
|
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies |
6.71 |
|
Transcriptomic analyssis following EHMT1/2 inhibition |
6.7 |
|
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] |
6.7 |
|
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors |
6.68 |
|
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] |
6.61 |
|
Fusion discovery in breast cancer cell line |
6.61 |
|
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease |
6.59 |
|
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate |
6.59 |
|
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 |
6.58 |
|
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. |
6.56 |
|
CircRNAome diversity in human mature B-cells, T-cells and monocytes |
6.5 |
|
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] |
6.46 |
|
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population |
6.41 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans |
6.39 |
|
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans |
6.39 |
|
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF |
6.36 |
|
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] |
6.36 |
|
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells |
6.36 |
|
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis |
6.36 |
|
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer |
6.32 |
|
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection |
6.31 |
|
Identification of renal resident macrophages across species [C1] |
6.3 |
|
Thyroid State Regulates Gene Expression in Human Whole Blood Cells |
6.23 |
|
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model |
6.19 |
|
RNA-seq of cells with TET1 knockout |
6.17 |
|
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. |
6.12 |
|
Leucegene: AML sequencing (part 6) |
6.07 |
|
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. |
6.04 |
|
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) |
6.0 |
|
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. |
5.94 |
|
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) |
5.94 |
|
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line |
5.88 |
|
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model |
5.79 |
|
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress |
5.75 |
|
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. |
5.7 |
|
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. |
5.64 |
|
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. |
5.64 |
|
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection |
5.63 |
|
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
5.61 |
|
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
5.61 |
|
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer |
5.6 |
|
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
5.56 |
|
Gene expression profile in breast cancer cells |
5.56 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line |
5.53 |
|
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element |
5.53 |
|
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids |
5.5 |
|
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells |
5.48 |
|
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. |
5.41 |
|
Transcriptomes of human monocytes after ex vivo exposure to uric acid |
5.4 |
|
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. |
5.36 |
|
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
5.32 |
|
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells |
5.32 |
|
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] |
5.31 |
|
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways |
5.31 |
|
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) |
5.28 |
|
RNA sequencing of human pancreatic cancer cell lines |
5.16 |
|
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites |
5.1 |
|
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 |
5.07 |
|
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment |
4.97 |
|
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells |
4.96 |
|
RNA-sequencing of human tendon after injury |
4.96 |
|
Targeted enhancer activation by a subunit of the integrator complex |
4.95 |
|
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions |
4.94 |
|
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells |
4.82 |
|
RNAseq of PRMT4KD in human cord blood derived CD34+ cells |
4.82 |
|
Expression and functions of long noncoding RNAs during human T helper cell differentiation |
4.75 |
|
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells |
4.74 |
|
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib |
4.67 |
|
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation |
4.6 |
|
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] |
4.44 |
|
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma |
4.44 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] |
4.39 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
4.13 |
|
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) |
4.07 |
|
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells |
4.06 |
|
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression |
4.06 |
|
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] |
4.06 |
|
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine |
4.04 |
|
FOXP3 protects conventional human T cells from premature restimulation-induced cell death |
4.02 |
|
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls |
3.99 |
|
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics |
3.99 |
|
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively |
3.91 |
|
UBC9 knockdown in bladder cancer T24 cell lines |
3.89 |
|
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans |
3.83 |
|
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma |
3.83 |
|
The effect of Abl kinases on non-small cell carcinoma global transcriptome |
3.75 |
|
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p |
3.73 |
|
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness |
3.73 |
|
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function |
3.69 |
|
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] |
3.69 |
|
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes |
3.68 |
|
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells |
3.48 |
|
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells |
3.44 |
|
A practical evaluation of alignment algorithms for RNA variant calling analysis |
3.41 |
|
Regulation of hypoxia-inducible factor activity by ZMYND8 |
3.38 |
|
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region |
3.37 |
|
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer |
3.35 |
|
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] |
3.35 |
|
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node |
3.25 |
|
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program |
3.22 |
|
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) |
3.22 |
|
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression |
3.2 |
|
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells |
3.14 |
|
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells |
3.13 |
|
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness |
3.1 |
|
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation |
3.09 |
|
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma |
3.0 |
|
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes |
2.95 |
|
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression |
2.95 |
|
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s |
2.95 |
|
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] |
2.94 |
|
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] |
2.93 |
|
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis |
2.93 |
|
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells |
2.92 |
|
Expression profiling of converted and control dermal BJ fibroblasts |
2.91 |
|
p63 establishes epithelial enhancers de novo at critical craniofacial development genes |
2.91 |
|
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer |
2.9 |
|
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets |
2.87 |
|
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology |
2.83 |
|
Methylation DNA mediated KLF4 binding activity in glioblastoma cells |
2.8 |
|
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii |
2.79 |
|
Transcriptomes in healthy and CHB fetal hearts |
2.78 |
|
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. |
2.77 |
|
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq |
2.76 |
|
Transcriptome analysis of peripheral blood monocytes |
2.75 |
|
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells |
2.69 |
|
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. |
2.68 |
|
Gene expression of thyroid cancer cell lines |
2.64 |
|
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics |
2.61 |
|
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 |
2.5 |
|
Identification of a LIF-responsive replication-competent human β cell |
2.49 |
|
Gene activation precedes DNA demethylation in response to infection in human dendritic cells |
2.48 |
|
Gene activation precedes DNA demethylation in response to infection in human dendritic cells |
2.48 |
|
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells |
2.4 |
|
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages |
2.38 |
|
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation |
2.38 |
|
Identification of renal resident macrophages across species |
2.36 |
|
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells |
2.34 |
|
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits |
2.34 |
|
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation |
2.34 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling |
2.24 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) |
2.24 |
|
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) |
2.19 |
|
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) |
2.19 |
|
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] |
2.18 |
|
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. |
2.18 |
|
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] |
2.17 |
|
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer |
2.03 |
|
Reprogrammed myeloid cell transcriptomes in NSCLC |
2.0 |
|
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing |
1.99 |
|
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming |
1.98 |
|
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells |
1.95 |
|
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia |
1.93 |
|
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases |
1.93 |
|
RNA-Seq and expression data from human adipose tissue |
1.93 |
|
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients |
1.92 |
|
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer |
1.89 |
|
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] |
1.89 |
|
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins |
1.79 |
|
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity |
1.74 |
|
Macrophage Ad5f35 PhenoMap |
1.74 |
|
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells |
1.7 |
|
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples |
1.63 |
|
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples |
1.63 |
|
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression |
1.63 |
|
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
1.58 |
|
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway |
1.58 |
|
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks |
1.54 |
|
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis |
1.53 |
|
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis |
1.51 |
|
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia |
1.49 |
|
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA |
1.49 |
|
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent |
1.48 |
|
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) |
1.48 |
|
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo |
1.48 |
|
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens |
1.45 |
|
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout |
1.44 |
|
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation |
1.42 |
|
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin |
1.42 |
|
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. |
1.42 |
|
Decoding breast cancer tissue-stroma interactions using species-specific sequencing |
1.41 |
|
Expression levels of genes of NKG2C+ NK cells after in vitro treatment |
1.4 |
|
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma |
1.38 |
|
Ribosome profiling upon inhibition of eIF4A |
1.37 |
|
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients |
1.34 |
|
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine |
1.32 |
|
RNA sequencing analysis of triple cytokine-captured human CD4 T cells |
1.23 |
|
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities |
1.19 |
|
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer |
1.19 |
|
Anti-inflammatory effect of indoleacrylic acid (IA) |
1.17 |
|
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq |
1.14 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) |
1.09 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers |
1.09 |
|
Clinker: visualizing fusion genes detected in RNA-seq data |
1.04 |
|
MRTF activates TEAD-YAP target gene expression |
1.02 |
|
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients |
0.94 |
|
The role of m6A/m-RNA methylation in stress response regulation |
0.94 |
|
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium |
0.94 |
|
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO |
0.91 |
|
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication |
0.83 |
|
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants |
0.83 |
|
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration |
0.78 |
|
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] |
0.73 |
|
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations |
0.73 |
|
mRNA sequencing of oropharyngeal cancer cell lines |
0.71 |
|
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway |
0.69 |
|
Generation and persistence of human tissue-resident memory T cells in lung transplantation |
0.68 |
|
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma |
0.67 |
|
RNA-seq of primary patient AML samples |
0.62 |
|
Human ovarian granulosa cell transcriptome |
0.58 |
|
RNA-sequencing in immortalized human mammary epithelial cells |
0.57 |
|
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer |
0.57 |
|
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer |
0.49 |
|
Transcriptomic analysis of human macrophages in 3D |
0.46 |
|
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas |
0.46 |
|
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells |
0.44 |
|
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] |
0.42 |
|
Specific molecular signatures underlie response to decitabine in CMML |
0.42 |
|
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors |
0.39 |
|
RNA editing in nascent RNA affects pre-mRNA splicing |
0.38 |
|
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history |
0.37 |
|
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression |
0.35 |
|
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells |
0.35 |
|
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency |
0.35 |
|
Frailty in middle age is associated with race-specific changes to the transcriptome. |
0.32 |
|
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes |
0.32 |
|
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants |
0.29 |
|
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants |
0.29 |
|
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma |
0.28 |
|
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. |
0.25 |
|
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming |
0.24 |
|
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells |
0.23 |
|
Gene expression analysis of breast cancer cell-lines |
0.18 |
|
Gene expression and genome-wide location analysis of breast cancer cell-lines |
0.18 |
|
Trascriptome of thyroid cancer-induced macrophages |
0.16 |
|
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis |
0.13 |
|
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis |
0.13 |
|
Persistence of stem cell metabolism in cancers as a failure of differentiation |
0.12 |
|
Gene expression of collecting duct carcinoma of the kidney |
0.09 |
|
MHC Transcriptomic landscape at haplotype-specific resolution |
0.03 |
|
Expression profile of MM.1S tumors folloiwing treatment with bortezomib |
0.03 |
|
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. |
0.01 |